Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday

Published 23/03/2023, 12:10
© Reuters.  89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday

Benzinga -

  • Baird cut the price target for Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) from $14 to $11. Baird analyst Justin Kleber maintained an Outperform rating. Petco Health and Wellness shares rose 0.2% to $8.41 in pre-market trading.
  • UBS increased the price target for KB Home (NYSE: KBH) from $45 to $48. UBS analyst John Lovallo maintained a Buy rating. KB Home shares gained 0.4% to close at $36.80 on Wednesday.
  • Barclays boosted the price target for Americold Realty Trust, Inc. (NYSE: COLD) from $30 to $32. Barclays analyst Anthony Powell upgraded the stock from Underweight to Equal-Weight. Americold Realty Trust shares rose 1.4% to $27.10 in pre-market trading.
  • Citigroup cut Diamondback Energy, Inc. (NASDAQ: FANG) price target from $170 to $157. Citigroup analyst Scott Gruber maintained a Buy rating. Diamondback Energy shares fell 2% to close at $127.96 on Wednesday.
  • Jefferies increased Inozyme Pharma, Inc. (NASDAQ: INZY) price target from $4.5 to $6. Jefferies analyst Suji Jeong upgraded the stock from Hold to Buy. Inozyme Pharma shares rose 7.7% to $3.20 in pre-market trading.
  • HC Wainwright & Co. cut the price target for Spruce Biosciences, Inc. (NASDAQ: SPRB) from $20 to $10. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Spruce Biosciences shares rose 13.3% to $2.56 in pre-market trading.
  • Needham boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $270 to $300. Needham analyst Rajvindra Gill maintained a Buy rating. NVIDIA shares gained 1% to close at $264.68 on Wednesday.
  • Keybanc cut Alkami Technology, Inc. (NASDAQ: ALKT) price target from $18 to $15. Keybanc analyst Josh Beck maintained an Overweight rating. Alkami Technology shares fell 4.8% to close at $12.02 on Wednesday.
  • Raymond James raised 89bio, Inc. (NASDAQ: ETNB) price target from $25 to $50. Raymond James analyst Steven Seedhouse maintained a Strong Buy rating. 89bio shares rose 25.2% to close at $13.68 on Wednesday.
  • Goldman Sachs increased Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) price target from $56 to $61. Goldman Sachs analyst Kate McShane maintained a Neutral rating. Ollie's Bargain Outlet shares rose 0.4% to $58.72 in pre-market trading.
  • JMP Securities boosted Phreesia, Inc. (NYSE: PHR) price target $34 to $39. JMP Securities analyst Joe Goodwin maintained an Outperform rating. Phreesia shares fell 6.3% to close at $33.59 on Wednesday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.